Fleming Asset Management is believed to be preparing a Luxembourg-based fund investing in life scienc...
Fleming Asset Management is believed to be preparing a Luxembourg-based fund investing in life sciences and biotech stocks around the world. The fund would be likely to take a global investment view, containing not just US stocks but also investments in the Far East, continental Europe and the UK, in order to capitalise fully on innovations in biotechnology and life sciences, and to leverage off the research capabilities Flemings' possesses around the world. The launch of a biotech-oriented fund could be appropriate, sector specialists say, given that the sector is currently undergoing a m...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes